Hypoxia activates Wnt/β-catenin signaling by regulating the expression of BCL9 in human hepatocellular carcinoma
Open accessThe DOI matches its Crossref record; 51 of the 51 references it cites were found in a registry or an index.
Abstract
The Wnt/β-catenin signaling is abnormally activated in the progression of hepatocellular carcinoma (HCC). BCL9 is an essential co-activator in the Wnt/β-catenin signaling. Importantly, BCL9 is absent from tumors originating from normal cellular counterparts and overexpressed in many cancers including HCC. But the mechanism for BCL9 overexpression remains unknown. Ample evidence indicates that hypoxia inducible factors (HIFs) play a role in the development of HCC. It was found in our study that BCL9 was overexpressed in both primary HCC and bone metastasis specimens; loss of BCL9 inhibited the proliferation, migration and angiogenesis of HCC; and that that hypoxia mechanically induced the expression of BCL9. BCL9 induction under the hypoxic condition was predominantly mediated by HIF-1α but not HIF2α. In vitro evidence from xenograft models indicated that BCL9 promoter/gene knockout inhibited HCC tumor growth and angiogenesis. Notably, we found that BCL9 and HIF-1α were coordinately regulated in human HCC specimen. The above findings suggest that hypoxia may promote the expression of BCL9 and associate with the development of HCC. Specific regulation of BCL9 expression by HIF-1α may prove to be an underlying crosstalk between Wnt/β-catenin signaling and hypoxia signaling pathways.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures







Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“Conversely, recent studies have demonstrated that bilirubin possesses signalling properties that can activate HIF and Wnt signalling cascades3,57, which are important for pericentral hepatocytes58.”
From Multi-zonal liver organoids from human pluripotent stem cells (2025) · cites this paper as [57]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Wnt/β-Catenin Signaling in Development and Disease
Clevers, H. (2006) · Cell · doi:10.1016/j.cell.2006.10.018 · Cited by 5,568
Hepatocellular Carcinoma: Epidemiology and Molecular Carcinogenesis
El–Serag, H. B., & Rudolph, K. L. (2007) · Gastroenterology · doi:10.1053/j.gastro.2007.04.061 · Cited by 5,415
Hypoxia — a key regulatory factor in tumour growth
Harris, A. L. (2002) · Nature Reviews Cancer · doi:10.1038/nrc704 · Cited by 5,177 · cited 1×
“Hypoxia is a common feature of all solid tumors and plays an essential role in tumor occurrence and development 16 .”
Targeting Hypoxia-Inducible Factors for the Treatment of Anemia in Chronic Kidney Disease Patients
Locatelli, F., Fishbane, S., Block, G. A., & Macdougall, I. C. (2017) · American Journal of Nephrology · doi:10.1159/000455166 · Cited by 4,813
Identification of c- MYC as a Target of the APC Pathway
He, T.-C., Sparks, A. B., Rago, C., Hermeking, H., Zawel, L., da Costa, L. T., Morin, P. J., Vogelstein, B., & Kinzler, K. W. (1998) · Science · doi:10.1126/science.281.5382.1509 · Cited by 4,566
β-Catenin regulates expression of cyclin D1 in colon carcinoma cells
Tetsu, O., & McCormick, F. (1999) · Nature · doi:10.1038/18884 · Cited by 3,601
Primary carcinoma of the liver.A study of 100 cases among 48,900 necropsies
Edmondson, H. A., & Steiner, P. E. (1954) · Cancer · doi:10.1002/1097-0142(195405)7:3<462::aid-cncr2820070308>3.0.co;2-e · Cited by 2,772
Hypoxia in cancer: significance and impact on clinical outcome
Vaupel, P., & Mayer, A. (2007) · Cancer and Metastasis Reviews · doi:10.1007/s10555-007-9055-1 · Cited by 2,240
Tankyrase inhibition stabilizes axin and antagonizes Wnt signalling
Huang, S.-M. A., Mishina, Y. M., Liu, S., Cheung, A., Stegmeier, F., Michaud, G. A., Charlat, O., Wiellette, E., Zhang, Y., Wiessner, S., et al. (2009) · Nature · doi:10.1038/nature08356 · Cited by 2,037
HIF-1α pathway: role, regulation and intervention for cancer therapy
Masoud, G. N., & Li, W. (2015) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2015.05.007 · Cited by 1,871 · cited 1×
“In addition, the difference in HIF1 α and HIF2 α gene selection can be attributed to their interactions with different transcription factors and/or chromatin context 42,43 .”
Cited by
Park, T.-E., Mustafaoglu, N., Herland, A., Hasselkus, R., Mannix, R., FitzGerald, E. A., Prantil-Baun, R., Watters, A., Henry, O., Benz, M., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-10588-0 · Cited by 594
Cancer Stem Cells: The Architects of the Tumor Ecosystem
Prager, B. C., Xie, Q., Bao, S., & Rich, J. N. (2019) · Cell Stem Cell · doi:10.1016/j.stem.2018.12.009 · Cited by 587
Mechanisms of vasculogenic mimicry in hypoxic tumor microenvironments
Wei, X., Chen, Y., Jiang, X., Peng, M., Liu, Y., Mo, Y., Ren, D., Hua, Y., Yu, B., Zhou, Y., et al. (2021) · Molecular Cancer · doi:10.1186/s12943-020-01288-1 · Cited by 463
Role of Wnt/β-catenin signaling in hepatocellular carcinoma, pathogenesis, and clinical significance
Khalaf, A. M., Fuentes, D., Morshid, A. I., Burke, M. R., Kaseb, A. O., Hassan, M., Hazle, J. D., & Elsayes, K. M. (2018) · Journal of Hepatocellular Carcinoma · doi:10.2147/jhc.s156701 · Cited by 227
Signaling pathways in hepatocellular carcinoma
(2021) · Advances in Cancer Research · doi:10.1016/bs.acr.2020.10.002 · Cited by 165
Xu, Q., Liu, X., Liu, Z., Zhou, Z., Wang, Y., Tu, J., Li, L., Bao, H., Yang, L., & Tu, K. (2017) · Molecular Cancer · doi:10.1186/s12943-017-0675-y · Cited by 165
Self-citationPei, Y.-F., Yin, X.-M., & Liu, X. (2017) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2017.10.019 · Cited by 148
Hepatocellular carcinoma: Mechanisms of progression and immunotherapy
Jiang, Y., Han, Q., & Zhang, J. (2019) · World Journal of Gastroenterology · doi:10.3748/wjg.v25.i25.3151 · Cited by 134
Wnt signaling in multiple myeloma: a central player in disease with therapeutic potential
Spaan, I., Raymakers, R. A., van de Stolpe, A., & Peperzak, V. (2018) · Journal of Hematology & Oncology · doi:10.1186/s13045-018-0615-3 · Cited by 115
Hypoxia‑inducible factors in hepatocellular carcinoma (Review)
Guo, Y., Xiao, Z., Liu, Y., Gao, Y., Zhu, Q., Hu, L., Huang, D., & Xu, Q. (2019) · Oncology Reports · doi:10.3892/or.2019.7397 · Cited by 120
Triple-negative breast cancer: understanding Wnt signaling in drug resistance
Merikhian, P., Eisavand, M. R., & Farahmand, L. (2021) · Cancer Cell International · doi:10.1186/s12935-021-02107-3 · Cited by 114
Targeting Hypoxia-Inducible Factor-1-Mediated Metastasis for Cancer Therapy
Ma, Z., Wang, L. Z., Cheng, J.-T., Lam, S. T., Ma, X., Xiang, X., Wong, A. L., Goh, B. C., Gong, Q., Sethi, G., et al. (2020) · Antioxidants and Redox Signaling · doi:10.1089/ars.2019.7935 · Cited by 107
Castellano, G., Franzin, R., Sallustio, F., Stasi, A., Banelli, B., Romani, M., De Palma, G., Lucarelli, G., Divella, C., Battaglia, M., et al. (2019) · Aging · doi:10.18632/aging.102059 · Cited by 95
Unraveling the triad of hypoxia, cancer cell stemness, and drug resistance
Shang, T., Jia, Z., Li, J., Cao, H., Xu, H., Cong, L., Ma, D., Wang, X., & Liu, J. (2025) · Journal of Hematology & Oncology · doi:10.1186/s13045-025-01684-4 · Cited by 100
Loss of BCL9/9l suppresses Wnt driven tumourigenesis in models that recapitulate human cancer
Gay, D. M., Ridgway, R. A., Müller, M., Hodder, M. C., Hedley, A., Clark, W., Leach, J. D., Jackstadt, R., Nixon, C., Huels, D. J., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-08586-3 · Cited by 92
Farzaneh, Z., Vosough, M., Agarwal, T., & Farzaneh, M. (2021) · Cancer Cell International · doi:10.1186/s12935-021-01924-w · Cited by 89
Luna, J. M., Barajas, J. M., Teng, K.-Y., Sun, H.-L., Moore, M. J., Rice, C. M., Darnell, R. B., & Ghoshal, K. (2017) · Molecular Cell · doi:10.1016/j.molcel.2017.06.025 · Cited by 80
Chen, P., Wang, F., Feng, J., Zhou, R., Chang, Y., Liu, J., & Zhao, Q. (2017) · Oncotarget · doi:10.18632/oncotarget.16896 · Cited by 76
Multi-zonal liver organoids from human pluripotent stem cells
Reza, H. A., Santangelo, C., Iwasawa, K., Reza, A. A., Sekiya, S., Glaser, K., Bondoc, A., Merola, J., & Takebe, T. (2025) · Nature · doi:10.1038/s41586-025-08850-1 · Cited by 71
Arinze, N. V., Yin, W., Lotfollahzadeh, S., Napoleon, M. A., Richards, S., Walker, J., Belghasem, M., Ravid, J. D., Kamel, M. H., Whelan, S. A., et al. (2021) · Journal of Clinical Investigation · doi:10.1172/jci142260 · Cited by 71
Wnt/β-Catenin signaling pathway in hepatocellular carcinoma: pathogenic role and therapeutic target
Zhao, Z., Cui, T., Wei, F., Zhou, Z., Sun, Y., Gao, C., Xu, X., & Zhang, H. (2024) · Frontiers in Oncology · doi:10.3389/fonc.2024.1367364 · Cited by 68
Investigations into the cancer stem cell niche using in-vitro 3-D tumor models and microfluidics
Sreepadmanabh, M., & Toley, B. J. (2018) · Biotechnology Advances · doi:10.1016/j.biotechadv.2018.03.009 · Cited by 60
Leung, R. W. H., & Lee, T. K. (2022) · Cancers · doi:10.3390/cancers14215468 · Cited by 57
P4HA1 regulates human colorectal cancer cells through HIF1α‑mediated Wnt signaling
Zhang, Q., Yin, Y., Zhao, H., Shi, Y., Zhang, W., Yang, Z., Liu, T., Huang, Y., & Yu, Z. (2020) · Oncology Letters · doi:10.3892/ol.2020.12406 · Cited by 57
Daly, L. A., Brownridge, P. J., Batie, M., Rocha, S., Sée, V., & Eyers, C. E. (2021) · Science Signaling · doi:10.1126/scisignal.abf6685 · Cited by 44
Tang, K. L., Toyozumi, T., Murakami, K., Sakata, H., Kano, M., Endo, S., Matsumoto, Y., Suito, H., Takahashi, M., Sekino, N., et al. (2022) · British Journal of Cancer · doi:10.1038/s41416-022-01825-3 · Cited by 49
Transcriptional profiles of mouse oligodendrocyte precursor cells across the lifespan
Heo, D., Kim, A. A., Neumann, B., Doze, V. N., Xu, Y. K. T., Mironova, Y. A., Slosberg, J., Goff, L. A., Franklin, R. J. M., & Bergles, D. E. (2025) · Nature Aging · doi:10.1038/s43587-025-00840-2 · Cited by 48
Zhou, S., Zhou, Z., Song, C., Xin, H., Hu, Z., Luo, C., Luo, Y., Li, J., Dai, Z., Yang, X., et al. (2022) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-021-00838-3 · Cited by 45
Li, D., Huifang, L., Zhao, J., Yang, Z., Xie, X., Wei, Z., Li, D., & Kang, P. (2018) · Biomedical Materials · doi:10.1088/1748-605x/aac627 · Cited by 44
Glucometabolic Reprogramming in the Hepatocellular Carcinoma Microenvironment: Cause and Effect
Tian, H., Zhu, X., Lv, Y., Jiao, Y., & Wang, G. (2020) · Cancer Management and Research · doi:10.2147/cmar.s258196 · Cited by 44
Sharma, M., Molehin, D., Castro‐Piedras, I., Martinez, E. G., & Pruitt, K. (2019) · Scientific Reports · doi:10.1038/s41598-019-52723-3 · Cited by 41
Molecular Mechanisms of the Therapeutic Effect of Selenium Nanoparticles in Hepatocellular Carcinoma
Varlamova, E. G. (2024) · Cells · doi:10.3390/cells13131102 · Cited by 40
Wnt status-dependent oncogenic role of BCL9 and BCL9L in hepatocellular carcinoma
Huge, N., Sandbothe, M., Schröder, A. K., Stalke, A., Eilers, M., Schäffer, V., Schlegelberger, B., Illig, T., Vajen, B., & Skawran, B. (2019) · Hepatology International · doi:10.1007/s12072-019-09977-w · Cited by 40
Wild, S. L., Elghajiji, A., Rodriguez, C. G., Weston, S. D., Burke, Z. D., & Tosh, D. (2020) · Genes · doi:10.3390/genes11101163 · Cited by 40
Hypoxia-Induced Signaling in Gut and Liver Pathobiology
Solanki, S. A., & Shah, Y. M. (2023) · Annual Review of Pathology Mechanisms of Disease · doi:10.1146/annurev-pathmechdis-051122-094743 · Cited by 38
Wang, X., Hassan, W., Jabeen, Q., Khan, G. J., & Iqbal, F. M. (2017) · Cytokine · doi:10.1016/j.cyto.2017.09.026 · Cited by 37
Alqurashi, N., Hashimi, S. M., Alowaidi, F., Ivanovski, S., & Wei, M. Q. (2018) · Oncology Reports · doi:10.3892/or.2018.6457 · Cited by 37
Orikasa, S., Kawashima, N., Tazawa, K., Hashimoto, K., Nara, K., Noda, S., Fujii, M., Akiyama, T., & Okiji, T. (2022) · Scientific Reports · doi:10.1038/s41598-021-04453-8 · Cited by 36
A HIF–LIMD1 negative feedback mechanism mitigates the pro‐tumorigenic effects of hypoxia
Foxler, D. E., Bridge, K. S., Foster, J. G., Grevitt, P., Curry, S., Shah, K., Davidson, K. M., Nagano, A., Gadaleta, E., Rhys, H. I., et al. (2018) · EMBO Molecular Medicine · doi:10.15252/emmm.201708304 · Cited by 35
Vafaizadeh, V., Buechel, D., Rubinstein, N., Kalathur, R. K. R., Bazzani, L., Saxena, M. T., Valenta, T., Hausmann, G., Cantù, C., Basler, K., et al. (2021) · Oncogene · doi:10.1038/s41388-021-02016-9 · Cited by 34
Hypoxia Activates SOX5/Wnt/β-Catenin Signaling by Suppressing MiR-338-3p in Gastric Cancer
Zheng, J., Que, Q.-Y., Xu, H., Luo, D.-S., Sun, Z., Ni, J.-S., Que, H., Ma, J., Wu, D., & Shi, H. (2020) · Technology in Cancer Research & Treatment · doi:10.1177/1533033820905825 · Cited by 31
Ye, J., Chen, K., Qi, L., Li, R., Tang, H., Zhou, C., & Zhai, W. (2018) · Oncology Reports · doi:10.3892/or.2018.6751 · Cited by 31
Yao, B., Li, Y., Wang, L., Chen, T., Niu, Y., Liu, Q., & Liu, Z. (2019) · Artificial Cells Nanomedicine and Biotechnology · doi:10.1080/21691401.2019.1670190 · Cited by 30
Self-citationRetractedZonation, Zonation, Zonation: The Real Estate of the Liver
Yasaka, T. M., Kim, C., Meadows, V., & Monga, S. P. (2025) · Annual Review of Pathology Mechanisms of Disease · doi:10.1146/annurev-pathmechdis-042624-091820 · Cited by 29
Trujano-Camacho, S., de León, D. F. C., Pérez-Yépez, E. A., Contreras-Romero, C., Coronel-Hernández, J., Millán-Catalán, O., Rodríguez‐Dorantes, M., López‐Camarillo, C., Gutiérrez‐Ruíz, M. C., Jacobo-Herrera, N. J., et al. (2024) · Cells · doi:10.3390/cells13171484 · Cited by 28
Huang, W., Zhang, C., Cui, M., Niu, J., & Ding, W. (2017) · Anticancer Research · doi:10.21873/anticanres.11821 · Cited by 27
Self-citationCell Competition Boosts Clonal Evolution and Hypoxic Selection in Cancer
Madan, E., Peixoto, M. L., Dimitrion, P. M., Eubank, T. D., Yekelchyk, M., Talukdar, S., Fisher, P. B., Mi, Q., Moreno, E., & Gogna, R. (2020) · Trends in Cell Biology · doi:10.1016/j.tcb.2020.10.002 · Cited by 26
Cruz-Burgos, M., Cortés-Ramírez, S. A., Losada-García, A., Morales-Pacheco, M., Martínez‐Martínez, E., Morales-Montor, J. G., Haddad-Servín, A., Izquierdo-Luna, J. S., Martinez, G. R., Ramos‐Godínez, M. D. P., et al. (2023) · Cancers · doi:10.3390/cancers15164148 · Cited by 24
Hypoxia-induced alternative splicing in human diseases: the pledge, the turn, and the prestige
Natua, S., Ashok, C., & Shukla, S. (2021) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-020-03727-0 · Cited by 24
Wnt Signaling: Paths for Cancer Progression
Carreira-Barbosa, F., & Nunes, S. C. (2020) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-34025-4_10 · Cited by 21
Hypoxic microenvironment and hepatocellular carcinoma treatment
Lin, C.-A., Chang, L.-L., Zhu, H., He, Q., & Yang, B. (2018) · Hepatoma Research · doi:10.20517/2394-5079.2018.27 · Cited by 20
Chen, K., Ye, J., Qi, L., Liao, Y., Li, R., Song, S., Zhou, C., Feng, R., & Zhai, W. (2019) · Anti-Cancer Drugs · doi:10.1097/cad.0000000000000797 · Cited by 20
Wnt/β-catenin signaling pathway in the tumor progression of adrenocortical carcinoma
Tai, Y., & Shang, J. (2024) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1260701 · Cited by 19
Sadeghi, F., Kardar, G. A., Bolouri, M. R., Nasri, F., Sadri, M., & Falak, R. (2020) · Biological Research · doi:10.1186/s40659-020-00293-4 · Cited by 18
Wu, M., Dong, H., Xu, C., Sun, M., Gao, H., Bu, F., & Chen, J. (2023) · Genes & Diseases · doi:10.1016/j.gendis.2023.03.012 · Cited by 18
Roles of Post-Translational Modifications of Transcription Factors Involved in Breast Cancer Hypoxia
Seymour, L., Nuru, N., Johnson, K. R., Villalpando-Gutierrez, J. M., Njoku, V. T., Darie, C. C., & Neagu, A.-N. (2025) · Molecules · doi:10.3390/molecules30030645 · Cited by 18
Haroon, M., & Kang, S. C. (2025) · Applied Biological Chemistry · doi:10.1186/s13765-025-00992-0 · Cited by 18
Zhao, Y., Liu, J.-F., Sun, W., Zeng, R.-F., Li, T., & Ma, R. (2018) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2018.08.079 · Cited by 18
Monteagudo, M., Calsina, B., Salazar-Hidalgo, M. E., Martínez‐Montes, Á. M., Piñeiro-Yáñez, E., Caleiras, E. J., Martín, M. C., Rodríguez, S., Letón, R., Gil, E., et al. (2024) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2024.101931 · Cited by 17
Zhang, W., Zhang, Y., Zhou, W., Qian, F., Hu, M., Chen, Y., Lü, J., Lou, Y., & Han, B. (2021) · Cancer Cell International · doi:10.1186/s12935-020-01714-w · Cited by 16
Self-citationZhang, H., Liu, C., Zhu, D., Zhang, Q., & Li, J. (2022) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.2c01016 · Cited by 16
Brown, T. C., Nicolson, N. G., Korah, R. M., & Carling, T. (2018) · Journal of the American College of Surgeons · doi:10.1016/j.jamcollsurg.2018.01.051 · Cited by 15
Zhang, Y., Zhang, M., Li, L., Wei, B., He, A., Lu, L., Li, X., Zhang, L., Xu, Z., & Sun, M. (2018) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.13660 · Cited by 14
Banerjee, M., & Rajeswari, V. D. (2022) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2022.103901 · Cited by 14
Wang, B., & Li, N. (2017) · Journal of Cellular Biochemistry · doi:10.1002/jcb.26576 · Cited by 12
RetractedWNT pathway signaling is associated with microvascular injury and predicts kidney transplant failure
Seifert, M. E., Gaut, J. P., Guo, B., Jain, S. R., Malone, A. F., Geraghty, F., Manna, D. L. D., Yang, E. S.-H., Yi, N., Brennan, D. C., et al. (2019) · American Journal of Transplantation · doi:10.1111/ajt.15372 · Cited by 10
Mishra, A. K., Singh, S., Dayanandan, S., Banerjee, S., Chakraborty, S., Gopal, A. B., Samal, S., Poirah, I., Chakraborty, D., & Bhattacharyya, A. (2022) · Cytokine · doi:10.1016/j.cyto.2022.155917 · Cited by 9
Luan, M., & Si, H. (2022) · Translational Cancer Research · doi:10.21037/tcr-22-253 · Cited by 9
Risato, G., Celeghin, R., Casas, R. B., Dinarello, A., Zuppardo, A., Vettori, A., Pilichou, K., Thiene, G., Basso, C., Argenton, F., et al. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2022.943127 · Cited by 9
Zhang, J., Ye, F.-L., Ye, A., & He, B. (2023) · Journal of Orthopaedic Surgery and Research · doi:10.1186/s13018-023-04251-0 · Cited by 8
Recent Advances in β-catenin/BCL9 protein–protein Interaction Inhibitors
Zhang, H., Bao, Y., Liu, C., Li, J., Zhu, D., & Zhang, Q. (2021) · Future Medicinal Chemistry · doi:10.4155/fmc-2020-0357 · Cited by 8
Kim, H.-R., Seo, C.-W., & Kim, J. (2023) · Osong Public Health and Research Perspectives · doi:10.24171/j.phrp.2023.0229 · Cited by 7
Sun, J., Jin, X., & Li, Y. (2024) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2024.167555 · Cited by 7
Ref-1 redox activity modulates canonical Wnt signaling in endothelial cells
Hartman, G. D., Sishtla, K. L., Kpenu, E. K., Mijit, M., Muniyandi, A., Jo, H., Junge, H. J., Shaw, A., Bischof, D., Liu, S., et al. (2025) · Redox Biology · doi:10.1016/j.redox.2025.103646 · Cited by 6
Schofield, C. L., Rodrigo‐Navarro, A., Dalby, M. J., Agtmael, T. V., & Salmerón‐Sánchez, M. (2021) · Advanced NanoBiomed Research · doi:10.1002/anbr.202000068 · Cited by 6
Wnt Signaling Pathway Is among the Drivers of Liver Metastasis
Samaržija, I. (2021) · Livers · doi:10.3390/livers1040015 · Cited by 6
Kim, Y., Kim, D. Y., Zhang, H., Bae, C., Seong, D., Kim, Y., Song, J., Kim, Y., & Kwon, Y. (2022) · BMC Biology · doi:10.1186/s12915-022-01240-3 · Cited by 5
Htun, M. W., Shibata, Y., Soe, K. T., & Koji, T. (2021) · ACTA HISTOCHEMICA ET CYTOCHEMICA · doi:10.1267/ahc.21-00090 · Cited by 5
BCL9/BCL9L in hepatocellular carcinoma: will it or Wnt it be the next therapeutic target?
Moghe, A., & Monga, S. P. (2020) · Hepatology International · doi:10.1007/s12072-020-10059-5 · Cited by 5
Leung, D. H. L. (2023) · Asia-Pacific Journal of Molecular Biology and Biotechnology · doi:10.35118/apjmbb.2023.031.2.03 · Cited by 4
Zheng, W., & Yao, D. (2018) · PubMed Central · doi:10.3760/cma.j.issn.1007-3418.2018.05.017 · Cited by 3
Identification of potential core genes in hepatoblastoma via bioinformatics analysisPreprint
Vastrad, B. M., Vastrad, C. M., & Kotturshetti, I. (2020) · medRxiv · doi:10.1101/2020.12.22.20248756 · Cited by 3
Human bone marrow-mesenchymal stem cells differentiation into brain-like endothelial cells
Soliman, Y., BARAN, G., & Mustafaoğlu, N. (2026) · TURKISH JOURNAL OF BIOLOGY · doi:10.55730/1300-0152.2786 · Cited by 2
Abbas, E. A. E. R., Barakat, A., Hassany, M., & Youssef, S. S. (2022) · Journal of Genetic Engineering and Biotechnology · doi:10.1186/s43141-021-00282-4 · Cited by 2
Cancer Stem Cells (CSCs) in Tumor Ecosystem
Saw, P. E., & Song, E. (2023) · Springer eBooks · doi:10.1007/978-981-99-1183-7_17 · Cited by 2
Hypoxia-driven Dental Pulp Stem Cells as a Promising Strategy for Tissue Regeneration
Liao, C., Chen, L., Xiang, M., Long, S., Xiang, M., Xiao, L., Long, Q., Liu, J., & Guan, X. (2024) · Current Stem Cell Research & Therapy · doi:10.2174/011574888x312892240625091241 · Cited by 1
Nie, Y., Liu, R., Sun, H., & Yao, Y. (2025) · Applied Biochemistry and Biotechnology · doi:10.1007/s12010-025-05459-y · Cited by 1
Pan, Z., Wu, H., Liu, Y., Yu, H., Shu, J., Yang, C., Wang, J., Du, F., Shao, M., & Zhou, H. (2025) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2025.117645 · Cited by 1
Self-citationSoe, M. T., Shibata, Y., Htun, M. W., Abe, K., Soe, K. T., Than, N. W., Lwin, T., Kyaw, M. P., & Koji, T. (2019) · ACTA HISTOCHEMICA ET CYTOCHEMICA · doi:10.1267/ahc.18045 · Cited by 1
Targeting cancer stem cells with phytoceuticals for cancer therapy
Park, I. S., Cho, J., Han, Y., Lee, K. W., & Song, Y. S. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-816151-7.00017-x · Cited by 1
The role of sodium driven bicarbonate transporters in triple negative breast cancer metastasis
Carroll, C. L. (2020) · Nottingham ePrints (University of Nottingham)
Deng, Y., Luo, H., Deng, Y., Yang, Y., Yao, X., Zhang, J., Su, Y., & He, B. (2021) · Research Square · doi:10.21203/rs.3.rs-509252/v1
Spaan, I. (2022) · Utrecht University Repository (Utrecht University) · doi:10.33540/1172
Rochford, G., Basar, R., Dhiman, R., Simitdjioglu, D., Thorne, L. S., Liloglou, L., Risk, J. M., & Hodges, N. J. (2022) · Preprints.org · doi:10.20944/preprints202208.0043.v1
AKTAŞ, G. İ., Kipel, Ş., Kozacı, L. D., & Özgüner, M. (2025) · Black Sea Journal of Engineering and Science · doi:10.34248/bsengineering.1606557
Schlaad, J. R. M. (2024) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.5.2024.tde-01072025-152009
Human Bone Marrow-Mesenchymal Stem Cells Differentiation Into Brain-Like Endothelial Cells|
Soliman Tolba, Y. S. M., BARAN, G., & Mustafaoğlu, N. (2023) · Sabanci University
Apilan, A. G. (2025) · TSpace (University of Toronto)
Differential cardiac microRNA expression in anoxic Trachemys scripta elegans turtles
Bloskie, T., Taiwo, O. O., Willmore, W. G., & Storey, K. B. (2026) · Biochimie · doi:10.1016/j.biochi.2026.06.018
Chambers, A., Reeves, M., Shrestha, A. P., Yarrapatni, S., Duarte, S. M., & Zarrinpar, A. (2026) · Current Oncology · doi:10.3390/curroncol33100576
Metadata
- Authors
- Xu, W., Zhou, W., Cheng, M., Wang, J., Liu, Z., He, S., Luo, X., Huang, W., Chen, T., Yan, W., & Xiao, J.
- Affiliations
- Second Military Medical University (CN)
- Xuzhou Medical College (CN)
- Fudan University (CN)
- Corresponding author
- Chen, Tianrui
- Yan, Wangjun
- Xiao, Jianru
- ORCID
- Venue
- Scientific Reports
- Published
- 2017-01-11
- Volume
- 7
- Issue
- 1
- Pages
- 40446-40446
- ISSN
- 2045-2322 (ISSN-L)
- PMC
- PMC5225427
- OpenAlex
- W2572807950
- Cited by
- 85
- References
- 51
- Citations by year
- 2026: 1 · 2025: 8 · 2024: 8 · 2023: 8 · 2022: 10 · 2021: 12 · 2020: 11 · 2019: 12 · 2018: 9 · 2017: 6
- FWCI
- 4.24
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by
- creativecommons.org/licenses/by/4.0 (tdm)
- creativecommons.org/licenses/by/4.0 (vor)
- Locations
- Scientific Reports (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Funders
- National Natural Science Foundation of China (81572746, 81201556, 81372874)
- China Postdoctoral Science Foundation (43302)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Wnt/β-catenin signaling in development and cancer
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Hypoxia, and Metabolism
- Health Sciences › Medicine › Hepatology › Hepatocellular Carcinoma Treatment and Prognosis
- Keywords
- hepatocellular carcinoma, hypoxia, Wnt/β-catenin signaling, BCL9, HIF-1α, HIF-2α, tumor hypoxia, bone metastasis, tumor angiogenesis, cell proliferation and migration, signaling crosstalk
- MeSH terms
- Transcription Activator-Like Effector Nucleases, Endothelial PAS Domain-Containing Protein 1, Adult, Animals, Base Sequence, Bone Neoplasms, Cell Movement, Female, Genetic Engineering, Carcinoma, Hepatocellular, Humans, Liver Neoplasms, Male, Mice, Nude, Middle Aged, Neoplasm Proteins, Neovascularization, Pathologic, Promoter Regions, Genetic, Transcription Factors, Transcriptional Activation, Cell Hypoxia, Gene Expression Regulation, Neoplastic, Response Elements, Cell Proliferation, Basic Helix-Loop-Helix Proteins, Hypoxia-Inducible Factor 1, alpha Subunit, Hep G2 Cells, Wnt Signaling Pathway
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.